IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available

Journal of Immunology

Volumn 175, Issue 2, 2005, Pages 788-795

  Khader, Shabaana A ^a   Pearl, John E ^a   Sakamoto, Kaori ^b   Gilmartin, Leigh ^a   Bell, Guy K ^a   Jelley Gibbs, Dawn M ^a   Ghilardi, Nico ^c   DeSauvage, Fred ^c   Cooper, Andrea M ^a  

^a TRUDEAU INSTITUTE   (United States)

^b Cornell University ^*  (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 23; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL GROWTH; BACTERIOSTASIS; CELL SPECIFICITY; CONTROLLED STUDY; COVALENT BOND; CYTOKINE PRODUCTION; FEMALE; GRANULOMATOUS INFLAMMATION; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS;

EID: 23244458100     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.2.788     Document Type: Article

References (46)

1. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement, global burden of tuberculosis: estimated incidence, prevalence and mortality by country. J. Am. Med. Assoc. 282: 677-686.
2. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, D. M. Getzy, and I. M. Orme. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84: 423-432.
3. Cooper, A. M., J. Magram, J. Ferrante, and I. M. Orme. 1997. IL-12 is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186: 39-45.
4. Kobayashi, M., L. Fitz, M. Ryan, R. Hewick, S. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827-845.
5. Presky, D. H., H. Yang, L. J. Minetti, A. O. Chua, N. Nabavi, C. Y. Wu, M. K. Gately, and U. Gubler. 1996. A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 93: 14002-14007.
6. Holscher, C., R. Atkinson, B. Arendse, N. Brown, E. Myburgh, G. Alber, and F. Brombacher. 2001. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167: 6957-6966.
7. Cooper, A. M., A. Kipnis, J. Turner, J. Magram, J. Ferrante, and I. M. Orme. 2002. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol. 168: 1322-1327.
8. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 13: 715-725.
9. Re, F., and J. Strominger. 2001. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 276: 37692-37699.
10. Parham, C., M. Chirica, J. Timans, E. Vaisberg, M. Travis, J. Cheung, S. Pflanz, R. Zhang, K. P. Singh, F. Vega, et al. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168: 5699-5708.
11. + T cell activation state characterised by the production of IL-17. J. Biol. Chem. 278: 190-1914.
12. Happel, K. I., M. Zheng, E. Young, L. J. Quinton, E. Lockhart, A. J. Ramsay, J. E. Shellito, J. R. Schurr, G. J. Bagby, S. Nelson, et al. 2003. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170: 4432-4436.
13. Aggarwal, S., and A. L. Gurney. 2002. IL-17: prototype member of an emerging cytofcine family. J. Leukocyte Biol. 71: 1-8.
14. Ghilardi, N., N. Kljavin, Q. Chen, S. Lucas, A. L. Gurney, and F. J. de Sauvage. 2004. Compromised humoral and delayed-type hypersensitivity responses in IL-23 deficient mice. J. Immunol. 172: 2827-2833.
15. Langrish, C., Y. Chen, W. Blumenschein, J. Mattson, B. Basham, J. Sedgwick, T. McClanahan, R. Kastelein, and D. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
16. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
17. Wiekowski, M. T., M. W. Leach, E. W. Evans, L. Sullivan, S. C. Chen, G. Vassileva, J. F. Bazan, D. M. German, R. A. Kastelein, S. Narula, et al. 2001. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J. Immunol. 166: 7563-7570.
18. Cua, D. I., I. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
19. Murphy, C. A., C. L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua. 2003. Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198: 1951-1957.
20. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA based α and β chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40.
21. Roberts, A., A. Cooper, J. Belisle, J. Turner, M. Gonzalez-Juarerro, and I. Orme. 2002. Murine models of tuberculosis. In Methods in Microbiology, Vol. 32. S. Kaufmann and D. Kabelitz, eds. Academic Press, London, p. 433-462.
22. Andersen, P. 1997. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand. J. Immunol. 45: 115-131.
23. Winslow, G., A. Roberts, M. Blackman, and D. Woodland. 2003. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J. Immunol. 170: 2046-2052.
24. Overbergh, L., D. Valckx, M. Waer, and C. Mathieu. 1999. Quantification of murine cytokine mRNAs using real time quantitative reverse transcription PCR. Cytokine 11: 305-312.
25. Johnson, L. L., K. Betggren, F. M. Szaba, W. Chen, and S. T. Smiley. 2003. Fibrin-mediated protection against infection-stimulated immunopathology. J. Exp. Med. 197: 801-806.
26. Rhoades, E. R., A. A. Frank, and I. M. Orme. 1997. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuberc. Lung Dis. 78: 57-66.
27. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
28. MacMicking, J. D., R. J. North, R. LaCourse, J. Mudgett, S. K. Shah, and Nathan C.F. 1997. Indentification of NOS2 as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94: 5243-5248.
29. MacMicking, J., G. Taylor, and J. McKinney. 2003. Immune control of tuberculosis by IFN-7-inducible LRG-47. Science 302: 654-659.
30. Linden, A., H. Hoshino, and M. Lann. 2000. Airway neutrophils and interleukin-17. Eur. Respir. J. 15: 973-977.
31. Miyamoto, M., O. Prause, M. Sjostrand, M. Laan, J. Lotvall, and A. Linden. 2003. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J. Immunol 170: 4665-4672.
32. Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al. 2001. Requirement of interleukin-17 receptor signalling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194: 519-527.
33. Lieberman, L. A., F. Cardillo, A. M. Owyang, D. M. Rennick, D. J. Cua, R. A. Kastelein, and C. A. Hunter. 2004. IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. J. Immunol. 173: 1887-1893.
34. Altare, F., A. Durandy, D. Lammas, J. F. Emile, S. Lamhamedi, F. Le Deist, P. Drysdale, E. Jouanguy, R. Doffinger, F. Bernaudin, et al. 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280: 1432-1435.
35. Doffinger, R., S. Dupius, C. Picard, C. Fieschi, J. Feinberg, G. Barcenas-Morales, and J.-L. Casanova. 2001. Inherited disorders of IL-12 and IFN-γ mediated immunity: a molecular genetics update. Mol. Immunol. 38: 903-909.
36. Jouanguy, E., Doffinger, R., S. Dupuis, A. Pallier, F. Altare, and J. L. Casanova, 1999. IL-12 and IFN-7 in host defense against mycobacteria and salmonella in mice and men. Curr. Opin. Immunol. 11: 346-351.
37. Lammas, D. A., J. L. Casanova, and D. S. Kumararatne. 2000. Clinical consequences of defects in the IL-12-dependent interferon-γ (IFN-γ) pathway. Clin. Exp. Immunol. 121: 417-425.
38. Ottenhof, T., D. Kumararante, and J. Casanova. 1998. Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunol. Today 19: 491-494.
39. Verreck, F. A. W., T. de Boer, D, M. L. Langenberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T. H. M. Ottenhoff. 2004. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101: 4560-4565.
40. Hoeve, M. A., T. de Boer, D. M. L. Lagenberg, O. Sanal, F. A. W. Verreck, and T. H. M. Ottenhoff. 2003. IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor β1 deficiency. Eur. J. Immunol. 33: 3393-3397.
41. Hellings, P. W., A, Kasran, Z. Liu, P. Vandekerckhove, A. Wuyts, L. Overbergh, C. Mathieu, and J. L. Ceuppens. 2003. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 28: 42-50.
42. Pearl, J. E., B. M. Saunders, S. Ehlers, I. M. Orme, and A. M. Cooper. 2001. Inflammation and lymphocyte activation during mycobacterial infection in the interferon-γ-deficient mouse. Cell. Immunol. 211: 43-50.
43. Moudgi, L. K. 1998. Diversification of response to hsp65 during the course of autoimmune arthritis is regulatory rather than pathogenic. Immunol. Rev. 164: 175-184.
44. Harrington, J. 1998. Mycobacterial and fungal arthritis. Curr. Opin. Rheumatol. 10: 335-338.
45. McGill, P. 2003. Geographically specific infections and arthritis, including rheumatic syndromes associated with certain fungi and parasites, Brucella species and Mycobacterium leprae. Best Pract. Res. Clin. Rheumatol. 17: 289-292.
46. Zhang, G., B. Gran, S. Yu, J. Li, I. Siglienti, X. Chen, M. Kamoun, and A. Rostami. 2003. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-β2 deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 170: 2153-2160.